• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 15-12G filed by Tabula Rasa HealthCare Inc.

    11/13/23 8:43:07 AM ET
    $TRHC
    Business Services
    Consumer Discretionary
    Get the next $TRHC alert in real time by email
    15-12G 1 ef20014456_15-12g.htm 15-12G

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


     
    FORM 15


     
    CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
    UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
    OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
    OF THE SECURITIES EXCHANGE ACT OF 1934.
     
    Commission File Number: 001-37888


     
    Tabula Rasa HealthCare, Inc.
    (Exact name of registrant as specified in its charter)


     
    228 Strawbridge Drive, Suite 100
    Moorestown, New Jersey 08057
    (866) 648-2767
    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
     
    Common Stock, par value $0.0001 per share
    (Title of each class of securities covered by this Form)
     
    None
    (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)



    Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

    Rule 12g-4(a)(1)
    ☒
    Rule 12g-4(a)(2)
    ☐
    Rule 12h-3(b)(1)(i)
    ☒
    Rule 12h-3(b)(1)(ii) 
    ☐
    Rule 15d-6
    ☐
    Rule 15d-22(b)
    ☐
     
    Approximate number of holders of record as of the certification or notice date: One (1)



    Pursuant to the requirements of the Securities Exchange Act of 1934, Tabula Rasa HealthCare, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

      
    TABULA RASA HEALTHCARE, INC.
         
    Date: November 13, 2023
    By:
    /s/ Brian W. Adams
        
    Name: Brian W. Adams
        
    Title:   President



    Get the next $TRHC alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $TRHC

    DatePrice TargetRatingAnalyst
    5/10/2023$7.00 → $10.00Market Perform → Outperform
    SVB Securities
    3/2/2022$30.00 → $15.00Buy
    Benchmark
    2/28/2022$23.00 → $11.00Market Perform
    SVB Leerink
    2/1/2022$24.00 → $11.00Outperform → Neutral
    Robert W. Baird
    2/1/2022$24.00 → $11.00Outperform → Neutral
    Baird
    12/2/2021$13.00Hold
    Jefferies
    11/8/2021$70.00 → $23.00Outperform
    RBC Capital
    11/8/2021$40.00 → $23.00Market Perform
    SVB Leerink
    More analyst ratings

    $TRHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Mitchell Ronald Paul returned 79,332 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Tabula Rasa HealthCare, Inc. (0001651561) (Issuer)

      11/14/23 9:09:01 PM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • Purcell Michael J. returned 139,322 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Tabula Rasa HealthCare, Inc. (0001651561) (Issuer)

      11/14/23 9:02:19 PM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • Schwartz Jonathan David returned 78,388 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Tabula Rasa HealthCare, Inc. (0001651561) (Issuer)

      11/14/23 8:59:36 PM ET
      $TRHC
      Business Services
      Consumer Discretionary

    $TRHC
    SEC Filings

    See more
    • SEC Form EFFECT filed by Tabula Rasa HealthCare Inc.

      EFFECT - Tabula Rasa HealthCare, Inc. (0001651561) (Filer)

      11/17/23 12:15:07 AM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • SEC Form EFFECT filed by Tabula Rasa HealthCare Inc.

      EFFECT - Tabula Rasa HealthCare, Inc. (0001651561) (Filer)

      11/17/23 12:15:26 AM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • SEC Form EFFECT filed by Tabula Rasa HealthCare Inc.

      EFFECT - Tabula Rasa HealthCare, Inc. (0001651561) (Filer)

      11/17/23 12:15:13 AM ET
      $TRHC
      Business Services
      Consumer Discretionary

    $TRHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Tabula Rasa HealthCare upgraded by SVB Securities with a new price target

      SVB Securities upgraded Tabula Rasa HealthCare from Market Perform to Outperform and set a new price target of $10.00 from $7.00 previously

      5/10/23 6:30:40 AM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • Benchmark reiterated coverage on Tabula Rasa HealthCare with a new price target

      Benchmark reiterated coverage of Tabula Rasa HealthCare with a rating of Buy and set a new price target of $15.00 from $30.00 previously

      3/2/22 7:40:57 AM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • SVB Leerink reiterated coverage on Tabula Rasa HealthCare with a new price target

      SVB Leerink reiterated coverage of Tabula Rasa HealthCare with a rating of Market Perform and set a new price target of $11.00 from $23.00 previously

      2/28/22 4:58:06 AM ET
      $TRHC
      Business Services
      Consumer Discretionary

    $TRHC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Rittenhouse Ventures Announces the Successful Close of Fund III, Reinforcing its Commitment to Capital-Efficient B2B SaaS, AI and Tech-Enabled Services Companies

      Rittenhouse Ventures, a leading venture capital firm with over 15 years of experience backing the country's top early-stage software founders, today announced the successful closing of Fund III. The new fund will build on the firm's strong track record of investing in capital-efficient, innovative B2B software, AI and tech-enabled services companies, with a particular focus on the Mid-Atlantic and other underserved regions across the United States. With the close of this fund, Rittenhouse Ventures has over $75M of assets under management. Rittenhouse Ventures Fund III continues the firm's commitment to partnering with emerging leaders in the software industry. "We are thrilled to be able

      7/9/25 8:00:00 AM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • Lifshitz Law PLLC Announces Investigations of VRTV, FRGI, TRHC, and SOVO

      NEW YORK, Aug. 12, 2023 (GLOBE NEWSWIRE) -- Veritiv Corporation (NYSE:VRTV) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of VRTV to an affiliate of Clayton, Dubilier & Rice, LCC for $170.00 per share in cash for each share of VRTV common stock owned. If you are a VRTV investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected]. Fiesta Restaurant Group, Inc. (NASDAQ:FRGI) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary dutie

      8/12/23 8:17:00 PM ET
      $FRGI
      $SOVO
      $TRHC
      $VRTV
      Restaurants
      Consumer Discretionary
      Packaged Foods
      Consumer Staples
    • Tabula Rasa HealthCare Reports Second Quarter 2023 Financial Results

      Continued Strong Organic Revenue Growth of 24% Second Quarter Adjusted EBITDA of $6.3 Million Increased More Than 3x Compared to Second Quarter 2022 MOORESTOWN, N.J., Aug. 7, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (NASDAQ:TRHC) ("TRHC" or the "Company"), a leading healthcare company advancing personalized, comprehensive care for value-based care organizations, today reported financial results for the second quarter ended June 30, 2023. Highlights from the second quarter ended June 30, 2023 include: Second quarter revenue from continuing operations of $90.0 million

      8/7/23 7:02:00 AM ET
      $TRHC
      Business Services
      Consumer Discretionary

    $TRHC
    Leadership Updates

    Live Leadership Updates

    See more
    • Tabula Rasa HealthCare Provides Corporate Updates

      Appoints Brian Adams as President and Chief Executive Officer and a Member of the Board of Directors, Effective Immediately Appoints Richard W. Rew II as Chief Legal Officer and Corporate Secretary Announces Preliminary Unaudited First Quarter 2023 Revenue Exceeding Guidance MOORESTOWN, N.J., April 13, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (NASDAQ:TRHC) ("TRHC" or the "Company"), a leading healthcare technology company advancing the safe use of medications, today announced the appointment of Brian Adams as President and Chief Executive Officer. Mr. Adams, who was serving as TRHC's interim Chief Executive Officer since September 2022 and previously served as the Company's Co-Pre

      4/13/23 4:05:00 PM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • Tabula Rasa HealthCare Names April Gill Chief Commercial Officer

      MOORESTOWN, N.J., Nov. 1, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ:TRHC), a leading healthcare technology company advancing the safe use of medications, today announced the appointment of April D. Gill as Chief Commercial Officer. Ms. Gill has more than 20 years of experience in healthcare with a proven track record exceeding client satisfaction, sales, and profitability goals. In this newly created role, Ms. Gill will oversee development and execution of TRHC's commercialization with broad responsibility for strategy, product, marketing, communication

      11/1/22 8:30:00 AM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • Tabula Rasa HealthCare Announces Leadership Transition

      Drs. Calvin H. Knowlton and Orsula V. Knowlton to retire from the Company Co-President Brian Adams Named Interim CEO Director Michael Purcell Named Independent Board Chairman MOORESTOWN, N.J., Sept. 14, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ:TRHC), a leading healthcare technology company advancing the safe use of medications, today announced that co-founders Dr. Calvin H. Knowlton, BScPharm, MDiv, PhD, ScD (hon), Chief Executive Officer and Board Chairman, and Dr. Orsula V. Knowlton, PharmD, MBA, Co-President and Chief Marketing and New Business Development Officer, will retire from TRHC and step down as members of the Board of Directors, effective immediately. Dir

      9/14/22 8:00:00 AM ET
      $TRHC
      Business Services
      Consumer Discretionary

    $TRHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Tabula Rasa HealthCare Inc. (Amendment)

      SC 13D/A - Tabula Rasa HealthCare, Inc. (0001651561) (Subject)

      8/8/23 4:01:33 PM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Tabula Rasa HealthCare Inc. (Amendment)

      SC 13G/A - Tabula Rasa HealthCare, Inc. (0001651561) (Subject)

      2/9/23 11:35:13 AM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • SEC Form SC 13D/A filed by Tabula Rasa HealthCare Inc. (Amendment)

      SC 13D/A - Tabula Rasa HealthCare, Inc. (0001651561) (Subject)

      9/14/22 3:21:21 PM ET
      $TRHC
      Business Services
      Consumer Discretionary

    $TRHC
    Financials

    Live finance-specific insights

    See more
    • Tabula Rasa HealthCare Reports Second Quarter 2023 Financial Results

      Continued Strong Organic Revenue Growth of 24% Second Quarter Adjusted EBITDA of $6.3 Million Increased More Than 3x Compared to Second Quarter 2022 MOORESTOWN, N.J., Aug. 7, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (NASDAQ:TRHC) ("TRHC" or the "Company"), a leading healthcare company advancing personalized, comprehensive care for value-based care organizations, today reported financial results for the second quarter ended June 30, 2023. Highlights from the second quarter ended June 30, 2023 include: Second quarter revenue from continuing operations of $90.0 million

      8/7/23 7:02:00 AM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • Tabula Rasa HealthCare Schedules Second Quarter 2023 Earnings Conference Call

      MOORESTOWN, N.J., July 25, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its second quarter 2023 financial results Tuesday, August 8, 2023 at 8:30 a.m. EDT. The Company's financial results for the second quarter 2023 ended June 30, 2023, will be released after the close of the market Monday, August 7, 2023. Those interested in participating via webcast in listen-only mode can access the event here. For participants who would like to participate via telephone, please register here to receive the dial-in numbe

      7/25/23 4:30:00 PM ET
      $TRHC
      Business Services
      Consumer Discretionary
    • Tabula Rasa HealthCare Reports First Quarter 2023 Financial Results

      First Quarter Results Show Benefits of Consistent Execution on Financial and Strategic Objectives First Quarter Revenue Growth of 32% Compared to First Quarter 2022 Raises Full Year 2023 Revenue and Adjusted EBITDA Guidance MOORESTOWN, N.J., May 8, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (NASDAQ:TRHC) ("TRHC" or the "Company"), a leading healthcare technology company advancing the safe use of medications, today reported financial results for the first quarter ended March 31, 2023. Highlights from the first quarter ended March 31, 2023, include: First quarter revenu

      5/8/23 4:30:00 PM ET
      $TRHC
      Business Services
      Consumer Discretionary